$14.74
0.352.43%
Last update: Oct 26, 9:27 AM
Erasca Inc (ERAS) Stock Price, Quote, News & History
ERASNASDAQ
Erasca reports early ERAS-0015 data showing tumor response while rejecting Revolution Medicines' patent and trade secret allegations.
You can purchase shares of Erasca (NASDAQ:ERAS) through any online brokerage.
Other companies in Erasca’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Erasca has a consensus price target of $14.21.
The stock price for Erasca (NASDAQ: ERAS) is $14.74 last updated October 26, 2026 at 9:27 AM EDT.
There are no upcoming dividends for Erasca.
Erasca does not have any upcoming earnings scheduled.
There is no upcoming split for Erasca.
Erasca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises...
